HIGH-GRADE B-CELL LYMPHOMA (HGBCL)
Clinical trials for HIGH-GRADE B-CELL LYMPHOMA (HGBCL) explained in plain language.
Never miss a new study
Get alerted when new HIGH-GRADE B-CELL LYMPHOMA (HGBCL) trials appear
Sign up with your email to follow new studies for HIGH-GRADE B-CELL LYMPHOMA (HGBCL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Last-Hope drug offered to patients with untreatable lymphoma
Disease control AVAILABLEThis program provides access to an experimental drug called odronextamab for patients with specific types of aggressive B-cell lymphoma that have returned or not responded to standard treatments. It is for people who have run out of approved treatment options. The goal is to try …
Matched conditions: HIGH-GRADE B-CELL LYMPHOMA (HGBCL)
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Apr 04, 2026 06:05 UTC
-
New 'Living Drug' trial seeks to tame tough blood cancers
Disease control Recruiting nowThis is an early-stage study testing the safety and best dose of a new CAR-T cell therapy called GF-CART01. It is for adults aged 18-70 with certain B-cell blood cancers that have come back or not responded to at least two prior treatments. The main goal is to find a safe dose an…
Matched conditions: HIGH-GRADE B-CELL LYMPHOMA (HGBCL)
Phase: PHASE1 • Sponsor: GenomeFrontier Therapeutics TW Co., Ltd. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC